Clinical Trial Update: Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1]

View source ↗

Summary

Phase I study of CWP232291 in patients with acute myeloid leukemia and related myeloid neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelofibrosis
• Myelomonocytic Leukemia

Drugs mentioned

• CWP232291

Snippet

Sponsor: JW Pharmaceutical | Conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 1 | Status: COMPLETED